TheEdgeResearch
Home / Stocks / NXSCF

Next Science Limited (NXSCF)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▼ -93.75%
Market Cap
$292,625
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
1.69
52-Wk Range
0.0002-0.1133
CEO
Matthew Franco Myntti
Country
AU
Currency
USD

Next Science Limited operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Sydney, NSW, AU. The stock last traded at $0.00, down 93.75% on the session, giving a market capitalisation of $292,625. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -46.4%. Its beta of 1.69 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.03
Price / Sales
0.01
Price / Book
0.08
EV / EBITDA
-0.12
Gross margin
80.8%
Operating margin
-45.2%
Net margin
-46.4%
Return on equity
—
Debt / equity
0.72
Current ratio
1.88
Dividend yield
10132.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
—
IPO date
2021-01-08
Headquarters
Sydney, NSW, AU
About Next Science Limited

Next Science Limited operates as an innovative medical technology company, committed to researching, developing, and commercializing advanced solutions that combat the detrimental effects of biofilms on human health in both the United States and Australia. The firm's product development is underpinned by its proprietary Xbio Technology platform. Its diverse portfolio includes SURGX, an antimicrobial gel designed for managing surgical infections; BACTISURE, a specialized wound lavage formulated to eliminate biofilm; BlastX, an antimicrobial wound gel that not only eradicates bacteria but also guards against recolonization, all while sustaining a moist healing environment; and XPERIENCE, a convenient, no-rinse antimicrobial solution aimed at preventing surgical site infections. Established in 2012, Next Science Limited is headquartered in Chatswood, Australia.

Comparable companies

Next Science Limited is most often compared with the following Healthcare names:

AHGIFCNTMFCWBHFELXMFEOFBFHSTIITHUFMEDIFPVCTWOWU
More research on NXSCF
NXSCF technical analysis NXSCF TheEdge Score Compare against peers
Open full interactive analysis & DCF →